Clinical trials
Treatment Decisions clinical trials
Below are recruiting treatment decisions clinical trials, each written for real people, not researchers. We’re tracking 59 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07842367RecruitingPhase 2
How inflammation affects doctors' decisions
This study looks at how inflammation in the body may affect doctors' thinking and treatment choices. As part of the study, you would receive a flu vaccine, and researchers will measure your body's response and how it might influence your medical decisions.
Fayetteville, ArkansasAges 18 years+ - NCT04290663RecruitingPhase 3
Radioiodine decision after thyroid surgery for intermediate-risk cancer
This study compares two approaches after thyroid surgery: giving radioactive iodine right away versus deciding based on follow-up test results. It aims to see which approach better helps people with intermediate-risk differentiated thyroid cancer.
Pointe à Pitre, GuadeloupeAges 18 years+ - NCT07481773Recruiting
Blood test to guide antibiotic decisions in the ICU
This trial uses a new blood test (called BV test) to help doctors decide if antibiotics should be stopped or continued for ICU patients with suspected or confirmed infections. It aims to reduce unnecessary antibiotic use while keeping patients safe.
Montreal, QuebecAges 18 years+ - NCT07010679Enrolling by invitation
How patients decide about sinus surgery
This study looks at how people with long-term sinus problems decide whether to have sinus surgery. Researchers want to understand what matters most to patients when choosing treatment.
Arcadia, CaliforniaAges 18 years+ - NCT07168629Recruiting
Community health workers help you get lung cancer screening
This trial tests whether a community health worker can help you get a lung cancer screening. If you are at risk for lung cancer and go to certain community health centers, this program may help you get the screening you need.
Springfield, MassachusettsAges 50–80 - NCT07009886Recruiting
Decision aid for advanced cancer patients considering more treatment
This study is testing a tool called TA-DA to help patients with advanced cancer and their caregivers make decisions about further treatment after at least two prior therapies. It aims to improve shared decision-making.
Houston, TexasAges 18 years+ - NCT06755710Recruiting
Patient engagement study for PTSD treatment
This trial tests whether a program that helps people actively take part in their PTSD treatment leads to better outcomes. It is designed for adults with PTSD, including refugees, and aims to improve treatment engagement and results.
Ballerup Municipality, Capital RegionAges 18 years+ - NCT07487714Enrolling by invitationPhase 4
Comparing amiodarone doses for paroxysmal AF
This study compares three different daily doses of the heart rhythm medication amiodarone to find the most effective one for preventing episodes of paroxysmal atrial fibrillation. Participants will take one of three doses (100, 200, or 400 mg) for up to 12 months, and the study will monitor how well each dose controls the irregular heartbeat.
TomskAges 18–80 - NCT05383911Recruiting
Sickle cell care plan choices for teens and young adults
This trial tests a way to help teens and young adults with sickle cell disease (SCD) and their caregivers actively take part in treatment decisions. It focuses on improving shared decision-making through interviews and a partner-centered approach.
Wilmington, DelawareAges 15 years+ - NCT06896474Recruiting
Breast cancer treatment choice help for women 70 and older
This study tests a decision aid to help women 70 and older with early stage breast cancer choose their treatment. It looks at whether the tool helps patients and their doctors make a confident treatment choice.
Los Angeles, CaliforniaAges 18 years+ - NCT06723990Recruiting
HER2 breast cancer treatment decision study
This study tests a tool called HER2DX to help doctors choose the best treatment for early stage HER2 positive breast cancer. It may help tailor therapy before or after surgery.
Milan, ItalyAges 18 years+ - NCT07073755Recruiting
Study of next treatments after targeted therapy resistance for advanced breast cancer
This study looks at what happens when people with advanced breast cancer switch to a new treatment after their cancer becomes resistant to targeted therapies like CDK4/6 inhibitors, PIK3CA inhibitors, or T-DXd. Researchers want to understand which next treatments work best in real life.
Changsha, HunanAges 18 years+ - NCT07713550Recruiting
Genetic profiling to guide treatment for advanced solid tumors
This study tests whether analyzing the DNA of your tumor (from a tissue sample or blood draw) can help find the best treatment for your advanced cancer. Researchers will look for genetic changes that could make you eligible for targeted therapy or a clinical trial.
AnderlechtAges 18 years+ - NCT07660146Recruiting
Predicting extraction needs for orthodontic treatment
This trial tests a method to help dentists decide if you need tooth extractions before braces. Researchers will look at dental models to see if this analysis tool is accurate.
Cairo, Giza GovernorateAges 12 years+ - NCT06738537Recruiting
Choosing treatment for mitral valve prolapse
This study looks at how to involve you in decisions about treating mitral valve prolapse, a condition where a heart valve doesn't close tightly. It aims to find the best way to help you and your doctor choose the right treatment.
Los Angeles, CaliforniaAges 21 years+ - NCT07532928Enrolling by invitation
Personalized Post-Surgery Care Plan for Advanced Head and Neck Cancer
This study helps doctors create a personalized plan for follow-up treatment after surgery for advanced head and neck cancer. Researchers will use imaging scans and patient data to predict which patients need extra treatment and which ones can be monitored closely instead.
GuangzhouAges 18 years+ - NCT07270666Recruiting
ctDNA test for guiding endometrial cancer treatment decisions
This trial tests whether a blood test for ctDNA (cancer DNA fragments) can help doctors decide if standard chemotherapy plus an immunotherapy drug is working for people with advanced or recurrent endometrial cancer. It may help tailor your treatment based on how the cancer responds.
Basking Ridge, New JerseyAges 18 years+ - NCT05717179Recruiting
Ultrasound-guided treatment choices for rheumatoid arthritis
This trial uses ultrasound to help decide how to adjust treatment in people with rheumatoid arthritis. It may help tailor therapy to keep the disease under better control using a treat-to-target approach.
Bruneck, BolzanoAges 18–84 - NCT07035951Recruiting
Family involvement for very old ICU patients
This study looks at how family members can be involved in making treatment decisions for older patients (75+) in the ICU. It aims to improve care for very old patients who are expected to stay in the ICU for more than 3 days.
LondonAges 75 years+ - NCT07027306Recruiting
New score to guide treatment for osteoporotic spine fractures
This study tests a new classification system to help doctors decide the best treatment for spine fractures caused by osteoporosis. It aims to improve pain and mobility by matching treatment to fracture type.
San Francisco, CaliforniaAges 50 years+ - NCT05719428RecruitingPhase 2
AI tool to guide treatment choices for hard-to-treat cancers
This trial tests an AI (neural network) decision-support tool that uses genetic test results to help guide treatment decisions in people with advanced solid tumors. It may help doctors choose better next steps when standard treatment options are no longer available.
SingaporeAges 21–99 - NCT06593080Recruiting
Testing a TB diagnosis checklist for children
This study is testing a new way to diagnose TB in children using simple symptom checklists. It aims to see if these checklists can help doctors find TB earlier and more accurately, especially in children who are very young or have other health problems.
Chingola, CopperbeltAges Up to 14 years - NCT06348719Recruiting
Robot vs. standard laparoscopy for early endometrial cancer
This trial compares two types of minimally invasive surgery (robot-assisted vs. conventional laparoscopy) for removing the uterus in people with early-stage, low- to intermediate-risk endometrial cancer. The goal is to see which approach offers the best value and outcomes.
LilleAges 18 years+ - NCT05878314Recruiting
Testing how hormones and tumor markers guide breast cancer treatment
This study looks at how planned hormone (endocrine) treatment, the menstrual cycle, and lab markers from the tumor may help doctors choose the best treatment for early-stage, hormone-receptor–positive, HER2-negative breast cancer. It may help personalize decisions, including what to do before surgery.
TübingenAges 18 years+
Hear when a new Treatment Decisions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment decisions?
- Yes. Clin2 currently lists 59 recruiting treatment decisions studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment decisions trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment decisions trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.